ABUS
Arbutus Biopharma Corp
NASDAQ: ABUS · HEALTHCARE · BIOTECHNOLOGY
$4.13
-0.48% today
Updated 2026-04-29
Market cap
$813.36M
P/E ratio
—
P/S ratio
57.75x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$3 – $5
Volume
2.5M
Arbutus Biopharma Corp (ABUS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |